ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.081,84
0,42%
S&P 500
5.901,73
-0,26%
Dow Jones
43.559,58
0,35%
Euro vs US Dollar
1,05347
-0,11%
Bitcoin
96.103,04
1,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) News

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FBIO
DatumZeitQuelleÜberschriftSymbolFirma
14/11/202422h10GlobeNewswire Inc.Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
14/11/202422h05GlobeNewswire Inc.Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
12/11/202422h01GlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
12/11/202414h30GlobeNewswire Inc.Mustang Bio Receives Positive Listing Determination from NasdaqNASDAQ:FBIOFortress Biotech Inc
07/11/202414h30GlobeNewswire Inc.Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant GliomaNASDAQ:FBIOFortress Biotech Inc
04/11/202413h00GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
25/10/202414h30GlobeNewswire Inc.Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceNASDAQ:FBIOFortress Biotech Inc
24/10/202420h10GlobeNewswire Inc.Mustang Bio Announces Exercise of Warrants for $4 Million Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
09/10/202414h30GlobeNewswire Inc.Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual SummitNASDAQ:FBIOFortress Biotech Inc
03/10/202414h30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:FBIOFortress Biotech Inc
26/09/202414h30GlobeNewswire Inc.Fortress Biotech to Participate in October 2024 Investor ConferencesNASDAQ:FBIOFortress Biotech Inc
20/09/202414h30GlobeNewswire Inc.Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private PlacementsNASDAQ:FBIOFortress Biotech Inc
09/09/202414h30GlobeNewswire Inc.Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202414h30GlobeNewswire Inc.Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202414h15GlobeNewswire Inc.Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
03/09/202414h30GlobeNewswire Inc.Avenue Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:FBIOFortress Biotech Inc
13/08/202422h05GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
12/08/202422h01GlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
09/08/202422h05GlobeNewswire Inc.Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
06/08/202422h01GlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:FBIOFortress Biotech Inc
25/07/202414h30GlobeNewswire Inc.Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027NASDAQ:FBIOFortress Biotech Inc
11/07/202422h05GlobeNewswire Inc.Journey Medical Corporation Appoints Michael C. Pearce to Board of DirectorsNASDAQ:FBIOFortress Biotech Inc
05/07/202422h05GlobeNewswire Inc.Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockNASDAQ:FBIOFortress Biotech Inc
21/06/202422h01GlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
20/06/202414h30GlobeNewswire Inc.Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:FBIOFortress Biotech Inc
20/06/202414h00GlobeNewswire Inc.Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
17/06/202414h30GlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:FBIOFortress Biotech Inc
16/05/202414h30GlobeNewswire Inc.Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)NASDAQ:FBIOFortress Biotech Inc
16/05/202414h00GlobeNewswire Inc.Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
15/05/202422h15GlobeNewswire Inc.Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:FBIO

Kürzlich von Ihnen besucht

USOTC
ACSKF
Arclands Corp Shs Japan (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten